Literature DB >> 16689860

Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.

Dagmar Simon1, Raija L P Lindberg, Evelyne Kozlowski, Lasse R Braathen, Hans-Uwe Simon.   

Abstract

Keratinocyte apoptosis mediated by Fas/Fas ligand molecular interactions and subsequent caspase activation is believed to play an important role in the pathogenesis of atopic dermatitis (AD), in particular for the formation of spongiosis. To estimate epidermal caspase activation in normal and AD skin under in vivo conditions, we analysed caspase-3 cleavage by immunohistology. In normal skin as well as non-lesional AD skin, we detected caspase-3 cleavage in single cells of the basal layer. In contrast, in acute lesional AD skin, we not only obtained evidence for increased expression of cleaved caspase-3 in keratinocytes of the basal layer but also observed caspase-3 cleavage in one or more layers of the spinous cell layer, in particular in spongiotic areas. Short-term topical treatment of the skin lesions with tacrolimus or pimecrolimus abolished the expression of cleaved caspase-3 in the spinous layer. Moreover, epidermal caspase-3 cleavage correlated with the numbers of dermal interferon-gamma (IFN-gamma)-expressing CD4+ and CD8+ lymphocytes in skin lesions of AD patients, supporting the view that IFN-gamma is important for the activation of proapoptotic pathways in keratinocytes. This is also confirmed by the observation of increased Fas expression on keratinocytes in acute AD lesions that was markedly reduced following topical calcineurin inhibitor treatment. These data suggest that caspase-3 cleavage in the spinous layer of the epidermis is a pathologic event contributing to spongiosis formation in AD, whereas cleavage of caspase-3 in basal cells might represent a physiologic mechanism within the process of epidermal renewal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689860     DOI: 10.1111/j.0906-6705.2006.00428.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  4 in total

1.  Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis.

Authors:  Shakeel Ahmad Khan; Ying Wu; Amy Sze-Man Li; Xiu-Qiong Fu; Zhi-Ling Yu
Journal:  BMC Complement Med Ther       Date:  2022-10-19

2.  HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

Authors:  Brian Giunta; Yuyan Zhou; Huayan Hou; Elona Rrapo; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 3.  Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis.

Authors:  Lily P H Yang; Monique P Curran
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  A human full-skin culture system for interventional studies.

Authors:  Lars Steinstraesser; Andrea Rittig; Kai Gevers; Michael Sorkin; Tobias Hirsch; Marco Kesting; Michael Sand; Sammy Al-Benna; Stefan Langer; Hans-Ulrich Steinau; Frank Jacobsen
Journal:  Eplasty       Date:  2009-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.